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التسمم بالرصاص نتيجة البتالع أفيون ملوث بالرصاص عند مريض أظهر 
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تقرير حالة
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abstract: Opium users may present with central or peripheral nervous system-related symptoms, gastrointestinal 
complications and anaemia; in such cases, lead poisoning should be suspected and chelation therapy initiated 
as soon as possible. We report a 64-year-old male patient with a 20-year history of opium addiction who was 
referred to the Imam Reza Hospital, Birjand, Iran, in 2017 with severe motor neuropathy and paresis in both upper 
limbs. His primary symptoms were generalised weakness, abdominal and bone pain, constipation and lower limb 
paraesthesia that had started several months prior. In addition, he reported severe progressive bilateral paresis 
of the upper limbs of one month’s duration. A diagnosis of lead poisoning was confirmed by a blood lead level of 
140 µg/dL. The patient underwent chelation therapy after which he improved significantly. At a one-year follow-up 
visit, he was neurologically intact and symptom-free. 
Keywords: Opium Dependence; Lead Poisoning; Lead-Induced Nervous System Diseases; Paresthesia; Case Report; 
Iran.
امللخ�ص: يظهر م�شتخدمو الأفيون اأعرا�شا مرتبطة باجلهازين الع�شبي املركزي والطريف وم�شاعفات معدية معوية وفقر دم؛ ويف هذه احلالت 
ينبغي ال�شتباه يف الت�شمم بالر�شا�س، والبدء يف العالج بالحتاد املخلبي باأ�رصع ما ميكن. ون�شجل هنا حالة رجل عمره 64 عاما ظل ي�شتخدم 
الأفيون ملدة 20 �شنة و�شار مدمنا له ومت حتويله عام 2017م اإىل م�شت�شفى الإمام ر�شا ببريجند يف اإيران، وهو م�شاب باعتالل ع�شبي مفرط 
وَخَزل بالطرفني العلويني. وكانت الأعر�س الرئي�شة عنده هي وهن عام، واآلم يف البطن والعظام، واإم�شاك، وَمَذل يف الطرفني ال�شفليني، وهي 
اأعرا�س بداأت عند هذا املري�س قبل عدة �شهور قبل حتويله للم�شت�شفى. كذلك حدث للمري�س َخَزل بالطرفني العلويني قبل نحو �شهر. واأثبت 
فح�س للدم وجود ت�شمم بالر�شا�س، اإذ اأن تركيزه بلغ 140 ميكروجرام/100 مل من الدم. ومت اإجراء عالج خملبي للمري�س اأدي لتح�شن حالة 
املري�س ب�شورة ملحوظة. وعند مراجعة املري�س للم�شت�شفى بعد عام على ذلك العالج وجد اأنه �شليم ع�شبيا ولي�شت لديه اأي اأعرا�س.
الكلمات املفتاحية: اإدمان الأفيون؛ الت�شمم بالر�شا�س؛ اأمرا�س اجلهاز الع�شبي التي ي�شببها الر�شا�س؛ َمَذل؛ تقرير حالة؛ اإيران.
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In recent years, lead poisoning due to the ingestion 
of lead-contaminated opium has become a major health 
concern in Iran.4–9 According to Ghane et al., more 
than 4,000 patients with lead poisoning due to opium 
ingestion were referred in under one year to clinical 
centres in Iran with abdominal pain and constipation.10 
Moreover, the researchers estimated that over 260,000 
out of >700,000 opium users remained untreated 
and at risk of lead poisoning.10 This case report describes 
a patient who presented to Imam Reza Hospital, the 
main referral centre for poisoning cases in the South 
Khorasan province of Iran, with severe lead-induced 
motor neuropathy due to the ingestion of lead-contam- 
inated opium.
Exposure to certain toxic agents results in neurotoxicity which may lead to cognitive and memory disabilities, mood changes and 
even predispose the affected patient to psychiatric 
problems such as depression, anxiety and irritability.1 In 
factories producing glazed tiles, canned food, paint and 
cosmetics, workers may be affected by the presence of 
inorganic lead; in addition, drinking water and dust may 
be contaminated from industrial sources and motor 
vehicles.2,3 Another source of potential exposure is the 
presence of organic lead in opium.4,5 Lead may be intent- 
ionally added to the drug to increase its weight for profit- 
related reasons or it may be introduced accidentally 
during the production process.4–7 Subsequently, the lead 
is ingested by opium users either orally or via inhalation.6,8
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Case Report
A 64-year-old male patient was referred to the Imam 
Reza Hospital, Birjand, in 2017 with generalised weak- 
ness, abdominal and bone pain, constipation and 
lower limb paraesthesia that had first started several 
months prior. The patient had then developed severe 
paresis in both upper limbs 30 days previously. He 
reported a 20-year history of oral opium use consisting 
of approximately 5 g daily. A urine drug analysis was 
positive for opium. Upon examination, the cranial nerves 
were normal, as were lower limb deep tendon reflexes; 
however, deep tendon reflexes in the upper limbs, biceps 
and triceps were absent. No sensory impairment was 
detected. The muscular power in the upper limbs 
was 2/5 and 1/5 in the proximal and distal areas, 
respectively, while the lower limbs were normal. The 
median and ulnar nerves were moderately affected, 
while the radial nerve was severely affected; the patient 
also had bilateral wrist drop. 
Imaging studies yielded normal results, including 
brain and cervical magnetic resonance imaging (MRI), 
computed tomography (CT), a chest X-ray and abdominal 
ultrasonography. Brain CT and MRI scans revealed 
no evidence of a mass, haemorrhage, hydrocephalus or 
abnormalities in the basal ganglia and posterior fossa 
structures. No established infarct and intra- or extra-axial 
collections were detected in the major vessel vascular 
territory. The basal cisterns and foramen magnum were 
patent. The chest X-ray showed an increase in bilateral 
bronchovascular markings with no other abnormalities. 
Whole body bone scintigraphy was performed to rule 
out malignancy; this showed only minor tracer uptake 
throughout the skeleton. An endoscopy and colonoscopy 
revealed a 7-mm polypoid lesion in the D1-D2 junction 
of the duodenum and internal haemorrhoids in the 
anus. Electromyography confirmed chronic motor- 
sensory polyneuropathy with axonal features which 
were more severe in the upper limbs. Critically, the 
patient’s blood lead level was 140 µg/dL (normal 
range: <10 µg/dL). Table 1 shows the results of various 
other laboratory tests. Nerve conduction and F-wave 
parameters are shown in Tables 2–4.
Based on his blood lead level, the patient was diagn- 
osed with lead poisoning and admitted to hospital. He 
was initially treated with 4 mg/kg of dimercaprol via 
deep intramuscular injection every four hours, followed 
by 1,300 mg/day of intravenous calcium disodium (CaNa2) 
edetate four hours after the first dose of dimercaprol. 
After five days of parenteral treatment, his blood lead 
level was 60 µg/dL. He was discharged and prescribed 
10 mg/kg of oral succimer, initially every eight hours for 
five days followed by every 12 hours for 14 days. After 
21 days of treatment, his clinical symptoms began to 
improve, particularly the abdominal pain, generalised 
Table 1: Laboratory test results of a 64-year-old male opium addict 
with severe lead-induced motor neuropathy
Variable Result Normal range
White blood cell count in ×103/mm3 8.1 4–10
Haemoglobin in g/dL 9.6 14–18
Haematocrit in % 30.5 Males: 45–52
Females: 37–48
MCV in femtolitres 83.6 80–96
MCH count in pg 27.1 27–33
MCHC in % 32.5 32–36
Platelet count in ×103/mm3 206 150–450
Vitamin B12 in pg/mL 1,178 160–950
Folic acid in ng/mL 6 2–20
Serum iron in µg/dL 36.8 65–176
TIBC in µg/dL 176 240–450
Ferritin in ng/mL 338.9 12–300
Serum vitamin D in ng/mL 9.55 20–50
T3 in pg/mL 4 2.3–4.2
T4 in ng/dL 9.9 4.5–11.5
TSH in µIU/mL 0.5 0.5–4.7
T3RU in % 36.7 24–37
AST in U/L 50 <37
ALT in U/L 55 <41
Alkaline phosphatase in U/L 188 80–306
Total bilirubin in mg/dL 1.2 <1.1
Direct bilirubin in mg/dL 0.4 <0.6
Creatinine in mg/dL 1 0.5–1.4
Prothrombin time in seconds 13 10–13.5
Partial thromboplastin time in seconds 28 25–35
INR 1 <1.1
Wright agglutination test Negative Negative
2ME Negative Negative
ANAs Negative Negative
Rheumatoid factor Negative Negative
Anti-ds-DNA in IU/mL 2.37 <10
Serum albumin in g/dL 3.6 3.5–5
α-globulin in g/dL 0.2 0.1–0.3
α-2-globulin in g/dL 0.8 0.6–1
β-globulin in g/dL 0.7 0.7–1.2
γ-globulin in g/dL 1.1 0.7–1.6
MCV = mean corpuscular volume; MCH = mean cell haemoglobin; MCHC = mean corpus-
cular haemoglobin concentration; TIBC = total iron-binding capacity; T3 = triiodothyronine; 
T4 = thyroxine; TSH = thyroid-stimulating hormone; T3RU = T3 resin uptake; AST = aspar-
tate aminotransferase; ALT = alanine aminotransferase; INR = international normalised ratio; 
2ME = 2-mercaptoethanol; ANAs = antinuclear antibodies; ds = double-stranded.
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weakness and weakness in the upper limbs. However, 
at a three-month follow-up appointment, the patient 
reported that the upper limb weakness still persisted; 
moreover, his blood lead level was 44 µg/dL. 
Due to a shortage of succimer, D-penicillamine 
treatment was initiated at a dose of 250 mg every eight 
hours for 10 days. After this, a neurological examination 
was normal, including examination of the power in the 
upper limbs, although the patient still complained of some 
upper limb weakness. He was referred to a rehabilitation 
clinic to undergo methadone maintenance therapy. 
One year later, his blood lead level was 20 μg/dL and 
the upper limb weakness had completely resolved.
Discussion
Symptoms of acute lead poisoning include nausea, head- 
aches, cognitive problems and emotional impairment, 
while chronic lead exposure may cause fatigue, a decline 
in brain and cognitive function, motor impairment, 
psychiatric problems and, in some cases, a decline in 
nerve conduction velocity.11,12 Critically, initial symptoms 
of irritability, headache, fatigue, memory loss and tremors 
may progress to weakness, limb paralysis, seizures, deli- 
rium and hallucinations, coma and, eventually, death.13 
As such, the early detection and immediate treatment 
of lead poisoning is imperative.
Neuropathy due to the ingestion of lead-contam- 
inated opium is uncommon, with most patients presenting 
with anaemia and gastrointestinal symptoms.14,15 A comb- 
Table 2: Motor nerve conduction parameters of a 64-year- 













Wrist 3.6 1.4 - -
Wrist-elbow 8.9 1.3 240 44.5
Left median APB
Wrist 3.3 1.0 - -
Wrist-elbow 8.2 0.959 240 39.3
Right ulnar ADM
Wrist 2.7 2.2 - -
Wrist-below 
elbow
7.0 1.9 260 40.8
Left ulnar ADM
Wrist 2.4 1.7 - -
Wrist-below 
elbow
7.1 1.5 260 39.4
Right radial EIP
Forearm Absent Absent - -
Elbow Absent Absent - -
Below spiral 
groove
Absent Absent - -
Left radial EIP
Forearm Absent Absent - -
Elbow Absent Absent - -
Below spiral 
groove
Absent Absent - -
Right DPN EDB
Ankle 3.5 1.8 - -
Ankle below 
FH
9.1 1.7 - -
Below FH-PF 9.8 1.8 350 41.3
Left DPN EDB
Ankle 5.1 1.8 - -
Ankle below 
FH
12.1 1.9 - -
Below FH-PF 12.8 1.8 340 38.4
Right tibial AHB
Medial ankle 6.3 3.1 - -
Medial ankle-
PF
14.3 2.9 380 37.7
Left tibial AHB
Medial ankle 5.1 3.9 - -
Medial ankle-
PF
13.6 4.3 380 44.3
APB = abductor pollicis brevis; ADM = abductor digiti minimi; EIP = 
extensor indicis proprius; DPN = deep peroneal nerve; EDB = extensor 
digitorum brevis; FH = fibula head; PF = popliteal fossa; AHB = 
abductor hallucis brevis.
Table 3: Sensory nerve conduction parameters of a 64-year-old 









Right median 4.0 14.6 130 43.1
Left median 3.6 9.64 130 47.2
Right ulnar 3.8 16.9 110 51.4
Left ulnar 3.5 14.3 110 50.4
Right radial 3.3 13.1 90 56.4
Left radial 3.1 15.3 90 60.5
Right sural 3.1 3.55 - -
Left sural 2.7 3.0 - -
Table 4: F-wave parameters of a 64-year-old male opium 
addict with severe lead-induced motor neuropathy




M F-M F min F max
Right median 
APB
4.3 24.2 28.6 31.1 0.11 50
Left median 
APB
3.7 22.0 25.7 32.1 0.14 60
Right ulnar 
ADM
0.1 28.2 28.3 33.0 0.07 100
Right tibial 
AHB
6.4 48.3 54.7 62.3 0.05 75
Left tibial 
AHB
0.1 54.1 54.2 54.7 0.03 66
min = minimum; max = maximum; APB = abductor pollicis brevis; 
ADM = abductor digiti minimi; HB = abductor hallucis brevis.
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ination of motor and sensory nervous system impair-
ment, as seen in the current case, is even less common. 
Lead-induced neuropathy commonly affects the radial 
and peroneal nerves and extensor muscles, resulting in 
wrist and foot drop, while sensory processing disorders 
are less frequent.2,16 Beigmohammadi et al. reported 
a 40-year-old male oral opium addict who presented 
with weakness of the limbs due to severe lead poisoning 
(blood lead level: 200 µg/dL).17 The patient had digestive 
symptoms (including stomach aches and constipation) 
and severe weakness of the upper and lower limbs, 
although sensation was normal. Despite treatment with 
CaNa2 edetate, dimercaprol and oral succimer, the patient 
remained quadriplegic, although both his blood lead 
levels and gastrointestinal symptoms improved.17 
Toxic-metabolic polyneuropathy may be induced 
by extrinsic or intrinsic metabolites which are toxic to 
the peripheral nerves, resulting in damage to the axial 
cylinders of the axons. The severity of this damage is 
dependent on the level of toxicity, duration of exposure 
and genetic characteristics of nervous tissue metabolism.18 
Clinically, the damage manifests as both sensory impair- 
ment and muscle weakness, although muscle wasting 
and severe trophic disorders may also occur. In these 
cases, electroneuromyography would show a decrease in 
the amplitude of peripheral nerve sensory potentials and 
muscle action potential.18 In patients with axonal-type 
polyneuropathy, there is often sufficient retention of 
motor function—in the absence of severe paresis—while 
sensory and trophic impairments are disabling. Axonal 
nerve damage develops slowly and gradually, although 
it is potentially reversible with appropriate treatment.18
In the current case, the patient developed both 
motor and sensory neuropathy due to long-term exposure 
to high levels of lead. However, all neurological symptoms 
completely resolved after treatment with chelating agents. 
Most patients with sensory complications are resistant to 
treatment and a full recovery is not expected, even after 
chelation therapy.16 This case emphasises the importance 
of the timely diagnosis and treatment of cases of lead 
toxicity in order to reverse central and peripheral nervous 
system-related symptoms.
Conclusion
Opium addicts are predisposed to developing lead toxicity 
resulting from the ingestion of lead-contaminated opium. 
This may result in the development of serious symptoms 
such as cognitive, sensory and motor impairment, with 
delays in diagnosis and treatment potentially resulting in 
irreversible neurological damage. As such, lead poisoning 
should be suspected among opium users with central or 
peripheral nervous system-related symptoms, gastro- 
intestinal complications and anaemia. Chelation therapy 
should be initiated as soon as possible in such cases.
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